[Melatonin as an inducing factor for multiple sclerosis]

Area of Science:

• Neuroimmunology
• Endocrinology

Background:

• Melatonin is a multifunctional hormone regulating nerve, endocrine, and immune systems.
• Its neuroprotective properties suggest potential in neurodegenerative diseases like multiple sclerosis (MS).
• Melatonin also modulates immune responses, including reactions to autoantigens.

Purpose of the Study:

• To investigate the complex role of melatonin in multiple sclerosis pathogenesis.
• To evaluate the impact of melatonin on T helper 17 (Th17) cells, which are implicated in MS.

Main Methods:

• Literature review and theoretical analysis of melatonin's immunomodulatory and neuroprotective effects.
• Focus on the interaction between melatonin and Th17 cell activity in the context of autoimmune diseases.

Main Results:

• Melatonin's neuroprotective effects are well-documented.
• However, its immunomodulatory actions on Th17 cells, crucial in MS, present a potential conflict.
• This interaction may theoretically counteract melatonin's beneficial neuroprotective activity in MS.

Conclusions:

• Melatonin's dual role in neuroprotection and immune modulation requires careful consideration for MS treatment.
• Further research is needed to elucidate the net effect of melatonin on Th17 cells in multiple sclerosis.
• Understanding this balance is critical for assessing melatonin's therapeutic potential in neurodegenerative and autoimmune conditions.